Overview

The last twenty-five years have witnessed an explosion of knowledge about the influence of brain biochemistry on mood and behavior and about pharmacological approaches to treating mental and emotional disorders. A substantial portion of patients seen in clinical practice are taking some medication or might usefully be advised to do so. But many clinical psychologists, social workers, and counselors need additional information in order to better treat patients already on medication, know when and to whom to refer new patients for psychiatric consultation, and work collaboratively with psychiatrists when appropriate. Michael J. Gitlin's indispensable first edition of The Psychotherapists Guide to Psychopharmacology has now been updated and revised -- this new second edition now reflects major changes that have influenced the clinical arena in the last five years such as the recent release of DSM-IV and the domination of the psychopharmacological field by the selective serotonin reuptake inhibitors, such as fluoxetine (Prozac). The Psychotherapists Guide to Psychopharmacology, Second Edition also now includes coverage of attention deficit/hyperactivity disorder and contains updated sections on the new antipsychotics for schizophrenia and the increased use of anticonvulsant mood stabilizers for bipolar disorder. The book also includes other significant changes that have influenced the field over the last few years, such as brain imaging studies, research in obsessive compulsive disorder and social phobia, and such prominent topics in women's health as pregnancy, PMS, postpartum disorders, and breast feeding. This revision of an already established guide will again be an essential reference for all nonmedical professionals involved in treating mental and emotional disorders.

Full Product Details

Author:   Michael J. Gitlin
Publisher:   Simon & Schuster
Imprint:   Simon & Schuster
Edition:   2nd Revised edition
Dimensions:   Width: 15.60cm , Height: 4.30cm , Length: 23.50cm
Weight:   0.771kg
ISBN:  

9780684827377

ISBN 10:   0684827379
Pages:   560
Publication Date:   01 May 1996
Audience:   College/higher education ,  General/trade ,  Professional and scholarly ,  Postgraduate, Research & Scholarly ,  General
Format:   Hardback
Publisher's Status:   Active
Availability:   In Print  
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

Contents List of Illustrations and Tables Preface Acknowledgments SECTION ONE 1. Diagnosis and Treatment: Basic Principles Descriptive Psychiatry and DSM-IV Pharmacotherapy and Its Implications for Other Therapies Evaluating Treatments: The Meaning of the Word Effective Goals of Pharmacotherapy Some General Issues in Psychopharmacological Treatment FDA Approval and PDR Doses Polypharmacy Practice Guidelines Who Should Have a Medication Consultation? SECTION TWO 2. Biological Basis of Psychopharmacology Neurotransmission: How Cells Communicate How Medications Work Neurotransmitters That Help Regulate Mood and Behavior Neuroimaging Techniques in Psychiatric Disorders Biological Hypotheses of the Major Psychiatric Disorders Mood Disorders Schizophrenia Anxiety Disorders SECTION THREE 3. Mood Disorders Diagnosis Major Depression Subtypes of Major Depressive Disorder Melancholic Depression Major Depression with Psychotic Features Atypical Depression Seasonal Depression Postpartum Depression Bipolar Disorder Natural History, Epidemiology, and Genetics Presentations of Mild Mood Disorders Dysthymia Cyclothymia Recurrent Brief Depressions and Minor Depressions Medical Differential Diagnosis and Evaluation Medications Causing Depression Laboratory Evaluation Psychiatric Differential Diagnosis Depression Mourning Demoralization Adjustment Disorder with Depressed Mood Premenstrual Syndrome Dementia Syndromes Mania Psychopharmacological Treatment Pharmacotherapy of Major Depression (Unipolar Depression) First-Line Agents Second-Line Agents Monoamine Oxidase (MAO) Inhibitors Electroconvulsive Treatment Other Options Mood Stabilizers Stimulants Light Therapy Antianxiety Agents Strategies Used in Treatment-Resistant Depressions Continuation Treatment of Unipolar Depression Maintenance Treatment of Unipolar Disorder Pharmacotherapy of Bipolar Disorder Treatment of Acute Manic Episodes Continuation Treatment of Manic or Hypomanic Episodes Bipolar Depression -- Acute and Continuation Treatment Maintenance Treatment of Bipolar Disorder 4. Anxiety Disorders and Insomnia Diagnosis Natural History, Epidemiology, and Genetics Medical Differential Diagnosis Medical and Laboratory Evaluation Psychiatric Differential Diagnosis Psychopharmacological Treatment Acute Treatment of Panic Disorder Continuation and Maintenance Treatment for Panic Disorder Social Phobia Obsessive Compulsive Disorder Post-traumatic Stress Disorder Generalized Anxiety Disorder Continuation and Maintenance Treatment of Generalized Anxiety Insomnia Diagnosis Treatment 5. Schizophrenia and Related Disorders Diagnosis Subtypes of Schizophrenia Natural History, Epidemiology, and Genetics Disorders Related to Schizophrenia Schizophreniform Disorder Schizoaffective Disorder Delusional Disorder Schizotypal Personality Disorder Medical Differential Diagnosis Laboratory Evaluation Psychiatric Differential Diagnosis Psychopharmacological Treatment Psychopharmacological Treatment of Acute Schizophrenia Alternative Treatments of Acute Schizophrenia Acute Treatment of Schizoaffective Disorder Continuation Treatment of Acute Schizophrenia Maintenance Treatment of Schizophrenia Maintenance Treatment of Schizoaffective Disorder Treatment of Depression in Schizophrenia 6. Disorders of Impulse Control: Eating Disorders, Drug and Alcohol Abuse, and Adult Attention Deficit/Hyperactivity Disorder (ADHD) Eating Disorders Anorexia Nervosa Bulimia Nervosa Adult Attention Deficit/Hyperactivity Disorder Psychopharmacological Treatment Alcohol and Drug Abuse Alcohol Abuse Cocaine Abuse Opiate Abuse (Heroin and Narcotic Analgesics) Other Drugs 7. Personality Disorders Diagnosis Subtypes Cluster A: Odd or Eccentric Personality Disorders Cluster B: Emotional or Chaotic Personality Disorders Cluster C: Anxious or Fearful Personality Disorders Natural History, Epidemiology, and Genetics Psychopharmacological Treatment of Personality Disorders Conceptual Models of Pharmacotherapy: What Are We Treating? Psychopharmacological Treatment of Specific Personality Disorders Cluster A: Odd or Eccentric Personality Types Cluster B: Emotional or Chaotic Personality Types Cluster C: Anxious or Fearful Types Depressive Spectrum Personality Disorders Management Issues 8. Treatment of Special Populations: Children/Adolescents, the Elderly, and Women Child and Adolescent Disorders Mood Disorders Diagnosis Pharmacotherapy Childhood Schizophrenia Diagnosis Pharmacotherapy Pervasive Developmental Disorders: Autistic Disorder, Asperger's Syndrome, and Related Entities Diagnosis Pharmacotherapy Anxiety Disorders Diagnosis Pharmacotherapy Attention Deficit/Hyperactivity Disorder Diagnosis Pharmacotherapy Sleep Disorders Diagnosis Pharmacotherapy Behavioral Conditions Enuresis Conduct Disorder Aggressive, Destructive Behavior in Mentally Retarded Children Tourette's Disorder Diagnosis Pharmacotherapy Geriatric Disorders Pharmacotherapy for Common Disorders Mood Disorders Psychotic Disorders Anxiety Disorders and Insomnia Medications Used in Treating Dementias Female-Specific Issues and Disorders Premenstrual Syndrome Medications During Pregnancy Antidepressants Antianxiety Drugs Mood Stabilizers Antipsychotics Electroconvulsive Treatment Postpartum Period and Breastfeeding Menopause SECTION FOUR 9. Antidepressants History Classification Cyclic Antidepressants Clinical Uses Biologic Effects Choosing a Cyclic Antidepressant Antidepressant Classes: Prescribing Techniques and Side Effects General Principles Selective Serotonin Reuptake Inhibitors (SSRIs) Novel Antidepressants Tricyclic Antidepressants (and Related Compounds) Monoamine Oxidase (MAO) Inhibitors Clinical Uses Biologic Effects Choice of Agents and Techniques for Prescribing Food and Drug Interactions Other Side Effects 10. Lithium and Other Mood Stabilizers History Lithium Clinical Uses Biologic Effects Techniques for Prescribing Side Effects Lithium's Effects on Thyroid and Kidneys Lithium Toxicity Lithium Discontinuation Anticonvulsant Mood Stabilizers Carbamazepine Clinical Uses Biologic Effects Techniques for Prescribing Side Effects Valproate Clinical Uses Biologic Effects Techniques for Prescribing Side Effects 11. Antianxiety Medications and Hypnotics History Benzodiazepines Clinical Uses Biologic Effects Choosing a Benzodiazepine Techniques for Prescribing Benzodiazepine Withdrawal Other Side Effects Zolpidem Buspirone Nonbarbiturate Sedatives and Hypnotics Barbiturates L-Tryptophan and Melatonin Antihistamines Clonidine Beta-blockers In the Future 12. Antipsychotics History Clinical Uses Biologic Effects Choosing an Antipsychotic Atypical Antipsychotics Techniques for Prescribing Side Effects Acute Side Effects Dystonic Reactions Akinesia Akathisia Neuroleptic Malignant Syndrome Non-Neurological Side Effects Tardive Dyskinesia Antiparkinsonian Medications 13. Electroconvulsive Therapy (ECT); Stimulants ECT Clinical Uses Mechanisms of Action Techniques of Administration Side Effects Stimulants Clinical Uses Mechanisms of Action Techniques of Administration Side Effects SECTION FIVE 14. The Split Treatment Model: Interactions Between Psychotherapy and Pharmacotherapy Early Models, Early Problems Psychotherapy/Pharmacotherapy Interactions: Theoretical Issues Therapeutic Split Model Advantages of the Split Model Disadvantages of the Split Model Psychodynamics of Psychopharmacology Patient Education Medication Compliance: Intra- and Interpersonal Factors Technical Aspects of Split Treatment Choosing a Psychopharmacologist Finding a Psychopharmacologist in Your Community or Group The Consultation Process The Initial Consultation Working in an Ongoing Split Treatment Appendix: Psychiatric Medications References Index

Reviews

Stanley R. Grahame, Ph.D. Clinical Director, Fifth Avenue Center for Counseling and Psychotherapy Director of Training, Greenwich Institute for Psychoanalytic Studies A concise, comprehensive review of the field of psychopharmacology which succeeds in communicating a mass of relevant data in an easily understandable text without talking down to the nonmedical psychotherapist. It is a triumph in communication of what every therapist should know about...patients who are receiving medication, who should be receiving medication, and who should not be receiving medication. The best book of its kind to date.

Robert O. Pasnau, M.D. Professor of Psychiatry, University of California, Los Angeles Chief of Staff, Neuropsychiatric Institute Hospital Assistant Dean, School of Medicine It is extremely useful for those psychiatrists, like me, who as psychotherapists are becoming increasingly convinced that combined pharmacology and psychotherapy is the treatment of choice of the majority of our patients. Most of my patients want to know why and how medications work, and they are becoming increasingly knowledgeable about side effects and dependency. Judith Marks Mishne, D.S.W. Professor, New York University School of Social Work This most readable, jargon-free text is clear, astute, and bridges the split between those physicians who prescribe medication and those therapists who do not....Dr. Gitlin's dual knowledge base and his respect for both methods of intervention are clear, as he demonstrates comfort with the split treatment model and collegial regard for the nonmedical clinician. This text is a must as a clinical guide for the nonphysician therapist. Lester Grinspoon, M.D. Associate Professor of Psychiatry, Harvard Medical School Editor, Harvard Medical School Mental Health Letter Since the introduction of chlorpromazine in 1953, a biological revolution has confronted psychotherapists with a vast array of medications which can enhance their effectiveness in treating a large variety of mental disorders. The practice of psychotherapy now requires an understanding of these drugs, including their indications, mechanisms of action, side effects, and especially the complex relationship between drug treatment and psychotherapy. For that purpose Gitlin's well-written, thorough, and comprehensive book is the best I have seen -- a text that will be useful not only to therapists without medical training but also to the psychopharmacologically sophisticated. Stanley R. Grahame, Ph.D. Clinical Director, Fifth Avenue Center for Counseling and Psychotherapy Director of Training, Greenwich Institute for Psychoanalytic Studies A concise, comprehensive review of the field of psychopharmacology which succeeds in communicating a mass of relevant data in an easily understandable text without talking down to the nonmedical psychotherapist. It is a triumph in communication of what every therapist should know about...patients who are receiving medication, who should be receiving medication, and who should not be receiving medication. The best book of its kind to date.

Lester Grinspoon, M.D.Associate Professor of Psychiatry, Harvard Medical School Editor, Harvard Medical School Mental Health Letter Since the introduction of chlorpromazine in 1953, a biological revolution has confronted psychotherapists with a vast array of medications which can enhance their effectiveness in treating a large variety of mental disorders. The practice of psychotherapy now requires an understanding of these drugs, including their indications, mechanisms of action, side effects, and especially the complex relationship between drug treatment and psychotherapy. For that purpose Gitlin's well-written, thorough, and comprehensive book is the best I have seen -- a text that will be useful not only to therapists without medical training but also to the psychopharmacologically sophisticated.

Author Information

Michael J. Gitlin, M.D. is an authority on psychopharmacology who has published numerous articles. He is Clinical Professor of Psychiatry and Director of the Affective Disorders Program and of the General Outpatient Clinic at the UCLA Neuropsychiatric Hospital.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions